(Press-News.org) A study of older patients with chronic obstructive pulmonary disease (COPD) suggests that new use of the long-acting bronchodilators β-agonists and anticholinergics was associated with similar increased risks of cardiovascular events, according to a study published Online First by JAMA Internal Medicine, a JAMA Network publication.
COPD affects more than 1 in 4 Americans older than 35 years of age and is the third leading cause of death in the United States. Medications are a mainstay of management of the disease. While there is little controversy about the effectiveness of long-acting β-agonists (LABAs) and long-acting anticholinergics (LAAs), their cardiovascular safety remains a matter of debate, according to the study background.
Andrea Gershon, M.D., M.S., of the Institute for Clinical Evaluative Sciences, Ontario, Canada, and colleagues conducted a nested case control analysis of a retrospective cohort study and compared the risk of cardiovascular events between patients newly prescribed the inhaled long-acting medications.
The study used health care databases from Ontario and included all individuals 66 years or older with a diagnosis of COPD who were treated from September 2003 through March 2009.
Of 191,005 eligible patients, 53,532 (28 percent) had a hospitalization or an emergency department visit for a cardiovascular event. According to the results, newly prescribed long-acting inhaled bronchodilators β-agonists and anticholinergics were associated with higher risk of a cardiovascular event compared with nonuse of those medications (respective adjusted odds ratios, 1.31 and 1.14). The results also indicate there was no significant difference in events between the two medications.
"Among older individuals with COPD, new use of long-acting β-agonists and anticholinergics is associated with similar increased risks of cardiovascular events. Close monitoring of COPD patients requiring long-acting bronchodilators is needed regardless of drug class," the study concludes.
(JAMA Intern Med. Published online May 20, 2013. doi:10.1001/jamainternmed.2013.1016. Available pre-embargo to the media at http://media.jamanetwork.com.)
Editor's Note: This study was supported by the government of Ontario, Canada, and various other funding sources. Please see article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.
Invited Commentary: Double-edged Sword? Long-Acting Bronchodilators in Chronic Obstructive Pulmonary Disease
In an invited commentary, Prescott G. Woodruff, M.D., M.P.H., of the University of California, San Francisco, writes: "No pharmacotherapy has been shown to meaningfully alter the rate of progression of chronic obstructive pulmonary disease (COPD). However, inhaled long-acting bronchodilators are mainstays of treatment in moderate to severe COPD because they improve lung function, dyspnea [shortness of breath], rate of exacerbations and quality of life."
"Ultimately, clinical trial data do not fully resolve the question of cardiovascular risks with LAMAs [muscarinic antagonists termed long-acting anticholinergics by Gershon et al] and LABAs [long-acting
inhaled β-agonists] because some of the data are discordant and because clinical trials generally exclude patients at greatest risk for cardiovascular complications," Woodruff continues.
"In conclusion, no single study will satisfactorily resolve the controversy, and at least three important questions cannot be addressed by this study. … Finally, although the authors recommend that 'subjects should be monitored closely,' a firm recommendation on what that monitoring should be cannot be made. Monitoring, of course, is the responsibility of an informed treating physician. The main contribution of this study is to highlight that responsibility," Woodruff concludes.
(JAMA Intern Med. Published online May 20, 2013. doi:10.1001/jamainternmed.2013.1201. Available pre-embargo to the media at http://media.jamanetwork.com.)
Editor's Note: The author made a conflict of interest disclosure and he is supported by grants from the National Institutes of Health and received grant funding from Genentech and Pfizer. Please see article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.
### END
Bronchodilators appear associated with increased risk of cardiovascular events
2013-05-21
ELSE PRESS RELEASES FROM THIS DATE:
2 radiotherapy treatments show similar morbidity, cancer control after prostatectomy
2013-05-21
Use of the newer, more expensive intensity-modulated radiotherapy (IMRT) and use of the older conformal radiotherapy (CRT) after surgical removal of all or part of the prostate gland were associated with similar morbidity and cancer control outcomes, according to a study published Online First by JAMA Internal Medicine, a JAMA Network publication.
Gregg H. Goldin, M.D., of the University of North Carolina at Chapel Hill, and colleagues analyzed data from the Surveillance, Epidemiology and End Results-Medicare-linked database to identify patients who received IMRT or CRT. ...
Association between in-hospital cardiac arrest survival rates, prevention of cardiac arrests
2013-05-21
Hospitals with higher rates of survival among patients who experience in-hospital cardiac arrest also appear to have a lower incidence of in-hospital cardiac arrest, according to a study published Online First by JAMA Internal Medicine, a JAMA Network publication.
Lena M. Chen, M.D., M.S., of the University of Michigan, Ann Arbor, and colleagues identified 102,153 cases of in-hospital cardiac arrest at 358 hospitals between January 2000 and November 2009.
The median (midpoint) hospital cardiac arrest incidence rate was 4.02 per 1,000 admissions, and the median hospital ...
Less sleep associated with increased risk of crashes for young drivers
2013-05-21
A study by Alexandra L. C. Martiniuk, M.Sc, Ph.D., of The George Institute for Global Health, Sydney, Australia, and colleagues suggests less sleep per night is associated with a significant increase in the risk for motor vehicle crashes for young drivers. (Online First)
Questionnaire responses were analyzed from 19,327 newly licensed drivers from 17 to 24 years old who held a first-stage provisional license between June 2003 and December 2004. Researchers also analyzed licensing and police-reported crash data, with an average of 2 years of follow up.
On average, ...
Bed sharing leads to fivefold increase in risk of cot death for babies whose parents do not smoke
2013-05-21
Parents who share a bed with their breastfed baby could face a fivefold increase in the risk of cot death, even if the parents do not smoke, according to a new study. The research was led by the London School of Hygiene & Tropical Medicine and is published in BMJ Open.
Cot death – also known as sudden infant death syndrome (SIDs) – remains a major cause of death among babies under 1 year of age in high income countries. There is already a general consensus that sleeping with a baby increases the risk of cot death if the parents smoke or if the mother has been drinking ...
May research highlights from American Journal of Tropical Medicine and Hygiene
2013-05-21
New Rapid Diagnostic Test for Worm Infection Provides Substantial Improvement Over Current Standard, According to New African Field Study; Provides Compass to Guide Public Health Efforts to Halt Debilitating Lymphatic Filariasis (Elephantiasis)
Two Studies on Efforts to Eliminate Onchocerciasis (River Blindness) in Africa:
a. In a First for East Africa, Scientists Provide Detailed Evidence that Onchocerciasis (River Blindness) May Be Eliminated After 14 Years of Long-term Mass Drug Treatment
b. Onchocerciasis (River Blindness) Could Make Comeback in Northwestern ...
Bed sharing with parents increases risk of cot death fivefold
2013-05-21
Bed sharing with parents is linked to a fivefold increased risk of sudden infant death syndrome (SIDS), even when the parents are non-smokers and the mother has not been drinking alcohol and does not use illegal drugs, according to a large analysis published online in BMJ Open.
While the rate of SIDS has fallen sharply following advice to parents to place babies to sleep on their back (supine), SIDS remains the major cause of infant death in the postneonatal period (28 days through to the first birthday) in developed countries.
Some countries, such as the Netherlands ...
The incidence of eating disorders is increasing in the UK
2013-05-21
More people are being diagnosed with eating disorders every year and the most common type is not either of the two most well known—bulimia or anorexia—but eating disorders not otherwise specified (eating disorders that don't quite reach the threshold to be defined as anorexia or bulimia), shows a study published online in BMJ Open.
Few studies have investigated the incidence of eating disorders, so the authors set out to determine the incidence of diagnosed anorexia nervosa, bulimia nervosa and other non-specified eating disorders in primary care over a 10-year period ...
Mediterranean diet seems to boost ageing brain power
2013-05-21
A Mediterranean diet with added extra virgin olive oil or mixed nuts seems to improve the brain power of older people better than advising them to follow a low-fat diet, indicates research published online in the Journal of Neurology Neurosurgery and Psychiatry.
The authors from the University of Navarra in Spain base their findings on 522 men and women aged between 55 and 80 without cardiovascular disease but at high vascular risk because of underlying disease/conditions.
These included either type 2 diabetes or three of the following: high blood pressure; an unfavourable ...
Protein study suggests drug side effects are inevitable
2013-05-21
A new study of both computer-created and natural proteins suggests that the number of unique pockets – sites where small molecule pharmaceutical compounds can bind to proteins – is surprisingly small, meaning drug side effects may be impossible to avoid. The study also found that the fundamental biochemical processes needed for life could have been enabled by the simple physics of protein folding.
Studying a set of artificial proteins and comparing them to natural proteins, researchers at the Georgia Institute of Technology have concluded that there may be no more than ...
New test better detects elephantiasis worm infection
2013-05-21
A new diagnostic test for a worm infection that can lead to severe enlargement and deformities of the legs and genitals is far more sensitive than the currently used test, according to results of a field study in Liberia, in West Africa, where the infection is endemic.
The new test found evidence of the infection – lymphatic filariasis – in many more people that the standard test had missed.
The study, the first to independently evaluate the new test, was led by researchers at Washington University School of Medicine in St. Louis and funded by the Bill & Melinda Gates ...